Literature DB >> 27824771

Maternal Deaths From Suicide and Overdose in Colorado, 2004-2012.

Torri D Metz1, Polina Rovner, M Camille Hoffman, Amanda A Allshouse, Krista M Beckwith, Ingrid A Binswanger.   

Abstract

OBJECTIVE: To ascertain demographic and clinical characteristics of maternal deaths from self-harm (accidental overdose or suicide) to identify opportunities for prevention.
METHODS: We report a case series of pregnancy-associated deaths resulting from self-harm in the state of Colorado between 2004 and 2012. Self-harm deaths were identified from several sources, including death certificates. Birth and death certificates along with coroner, prenatal care, and delivery hospitalization records were abstracted. Descriptive analyses were performed. For context, we describe demographic characteristics of women with a maternal death from self-harm and all women with live births in Colorado.
RESULTS: Among the 211 total maternal deaths in Colorado over the study interval, 30% (n=63) resulted from self-harm. The pregnancy-associated death ratio from overdose was 5.0 (95% confidence interval [CI] 3.4-7.2) per 100,000 live births and from suicide 4.6 (95% CI 3.0-6.6) per 100,000 live births. Detailed records were obtained for 94% (n=59) of women with deaths from self-harm. Deaths were equally distributed throughout the first postpartum year (mean 6.21±3.3 months postpartum) with only six maternal deaths during pregnancy. Seventeen percent (n=10) had a known substance use disorder. Prior psychiatric diagnoses were documented in 54% (n=32) and prior suicide attempts in 10% (n=6). Although half (n=27) of the women with deaths from self-harm were noted to be taking psychopharmacotherapy at conception, 48% of them discontinued the medications during pregnancy. Fifty women had toxicology testing available; pharmaceutical opioids were the most common drug identified (n=21).
CONCLUSION: Self-harm was the most common cause of pregnancy-associated mortality, with most deaths occurring in the postpartum period. A four-pronged educational and program building effort to include women, health care providers, health care systems, and both governments and organizations at the community and national levels may allow for a reduction in maternal deaths.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27824771      PMCID: PMC5121076          DOI: 10.1097/AOG.0000000000001695

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  37 in total

1.  Pregnancy-Associated Death in Utah: Contribution of Drug-Induced Deaths.

Authors:  Marcela C Smid; Nicole M Stone; Laurie Baksh; Michelle P Debbink; Brett D Einerson; Michael W Varner; Adam J Gordon; Erin A S Clark
Journal:  Obstet Gynecol       Date:  2019-06       Impact factor: 7.661

2.  Maternal drug-related death and suicide are leading causes of postpartum death in California.

Authors:  Sidra Goldman-Mellor; Claire E Margerison
Journal:  Am J Obstet Gynecol       Date:  2019-06-04       Impact factor: 8.661

3.  Early lessons from maternal mortality review committees on drug-related deaths-time for obstetrical providers to take the lead in addressing addiction.

Authors:  Marcela C Smid; Charles W Schauberger; Mishka Terplan; Tricia E Wright
Journal:  Am J Obstet Gynecol MFM       Date:  2020-07-15

4.  Medicaid Coverage of Methadone Maintenance and the Use of Opioid Agonist Therapy Among Pregnant Women in Specialty Treatment.

Authors:  Marcus A Bachhuber; Pooja K Mehta; Laura J Faherty; Brendan Saloner
Journal:  Med Care       Date:  2017-12       Impact factor: 2.983

5.  The association between medical comorbidity and Healthcare Effectiveness Data and Information Set (HEDIS) measures of treatment initiation and engagement for alcohol and other drug use disorders.

Authors:  Ingrid A Binswanger; Nikki M Carroll; Brian K Ahmedani; Cynthia I Campbell; Irina V Haller; Rulin C Hechter; Jennifer McNeely; Bobbi Jo H Yarborough; Andrea H Kline-Simon; Derek D Satre; Constance Weisner; Gwen T Lapham
Journal:  Subst Abus       Date:  2019-01-24       Impact factor: 3.716

6.  Maternal and infant characteristics associated with maternal opioid overdose in the year following delivery.

Authors:  Timothy Nielsen; Dana Bernson; Mishka Terplan; Sarah E Wakeman; Amy M Yule; Pooja K Mehta; Monica Bharel; Hafsatou Diop; Elsie M Taveras; Timothy E Wilens; Davida M Schiff
Journal:  Addiction       Date:  2019-11-13       Impact factor: 6.526

7.  Amphetamine- and Opioid-Affected Births: Incidence, Outcomes, and Costs, United States, 2004-2015.

Authors:  Lindsay K Admon; Gavin Bart; Katy B Kozhimannil; Caroline R Richardson; Vanessa K Dalton; Tyler N A Winkelman
Journal:  Am J Public Health       Date:  2018-11-29       Impact factor: 9.308

8.  Psychiatry and Obstetrics: An Imperative for Collaboration.

Authors:  M Camille Hoffman; Katherine L Wisner
Journal:  Am J Psychiatry       Date:  2017-03-01       Impact factor: 18.112

Review 9.  Challenges and Opportunities in Identifying, Reviewing, and Preventing Maternal Deaths.

Authors:  Amy St Pierre; Julie Zaharatos; David Goodman; William M Callaghan
Journal:  Obstet Gynecol       Date:  2018-01       Impact factor: 7.661

10.  Four maternal characteristics determine the 12-month course of chronic severe postpartum depressive symptoms.

Authors:  Sheehan D Fisher; Dorothy K Sit; Amy Yang; Jody D Ciolino; Jackie K Gollan; Katherine L Wisner
Journal:  Depress Anxiety       Date:  2019-01-15       Impact factor: 6.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.